Effect of probiotics on the occurrence of nutrition absorption capacities in healthy children: a randomized double-blinded placebo-controlled pilot study

被引:94
作者
Ballini, A. [1 ,2 ]
Gnoni, A. [3 ]
De Vito, D. [3 ]
Dipalma, G. [4 ]
Cantore, S. [3 ]
Isacco, C. Gargiulo [4 ]
Saini, R. [3 ]
Santacroce, L. [5 ]
Topi, S. [6 ]
Scarano, A. [7 ,8 ]
Scacco, S. [3 ]
Inchingolo, F. [4 ]
机构
[1] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy
[3] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
[4] Univ Ban Aldo Moro, Sch Med, Dept Interdisciplinary Med, Bari, Italy
[5] Univ Ban Aldo Moro, Ionian Dept, Bari, Italy
[6] A Xhuvani Univ, Sch Tech Med Sci, Elbasan, Albania
[7] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy
[8] Univ G dAnnunzio, CeSi MeT, Chieti, Italy
关键词
Probiotic bacteria; Prebiotics; Synbiotics; Human health; Gut microbiota; Translational medicine; ANTIBIOTIC-ASSOCIATED DIARRHEA; PREVENTION; PREBIOTICS; MICROBIOTA; TRIAL;
D O I
10.26355/eurrev_201910_19182
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Recent advances in the translational research showed that dietary nutrients have critical importance to the microbioma balance in the gastrointestinal tract. Therefore, the alteration of the intestinal microbiota in order to achieve, restore, and maintain favorable balance in the ecosystem, and the activity of microorganisms present in the gastrointestinal tract is necessary for the improved health condition of the host. The objective of this translational study was to evaluate, in a pediatric population, the efficacy and safety of prophylactic probiotics for a better nutritional absorption capacity in the view to enhance their overall health and immunity. PATIENTS AND METHODS: A total of 40 pediatric patients between the ages of 14 and 18 years were enrolled in the study and divided under two categories (treated/active group and placebo group). Three-time points clinical evaluations were performed: a baseline assessment (Time 0), a second evaluation at 5 weeks after the start of probiotic use (Time 1), and a final evaluation at the timeline after 10 weeks (Time 2). In the initial phase of the study, the recruited subjects underwent a panel of initial TO clinical tests. For each of the patients, a blood sample was taken in order to evaluate the following biochemical measurements: Vitamin D, Vitamin A, Calcium. Zinc, and Iron. Moreover, an initial nutritional evaluation was carried out through which the nutritionist estimated the body composition of the subject (weight and body mass index), the caloric needs and dietary behaviour of each recruited patient. RESULTS: Eligible participants were randomized into placebo (n = 20) or treated/active (n = 20) treatment conditions by random allocation using a computerized random number generator, ensuring all investigators remained blind to the treatment distribution. The data were compared within and between groups using statistical methods. The results confirmed that the probiotic supplementation was effective in increasing the overall blood biomarkers levels of vitamins. calcium, and mineral absorption from baseline to 10 weeks of treatment, compared with the placebo. CONCLUSIONS: Probiotics may be suggested as supplements to improve biomarkers serum concentration if administered for a period of at least >= 5 weeks. However, further studies are required for optimal recommendations in patient treatment.
引用
收藏
页码:8645 / 8657
页数:13
相关论文
共 25 条
  • [1] Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study
    Ballini, Andrea
    Santacroce, Luigi
    Cantore, Stefania
    Bottalico, Lucrezia
    Dipalma, Gianna
    Topi, Skender
    Saini, Rajiv
    De Vito, Danila
    Inchingolo, Francesco
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (03) : 373 - 381
  • [2] Ballini Andrea, 2018, Open Access Maced J Med Sci, V6, P1845, DOI 10.3889/oamjms.2018.406
  • [3] Brown Amy C, 2004, Nutr Clin Care, V7, P56
  • [4] Campanella V, 2018, EUR REV MED PHARMACO, V22, P8034, DOI 10.26355/eurrev_201811_16433
  • [5] Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations
    Canani, Roberto Berni
    Cirillo, Pia
    Terrin, Gianluca
    Cesarano, Luisa
    Spagnuolo, Maria Immacolata
    De Vincenzo, Anna
    Albano, Fabio
    Passariello, Annalisa
    De Marco, Giulio
    Manguso, Francesco
    Guarino, Alfredo
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7615): : 340 - +
  • [6] Ceresola ER, 2018, EUR REV MED PHARMACO, V22, P7045, DOI 10.26355/eurrev_201810_16177
  • [7] Next generation probiotics in disease amelioration
    Chang, Chih-Jung
    Lin, Tzu-Lung
    Tsai, Yu-Ling
    Wu, Tsung-Ru
    Lai, Wei-Fan
    Lu, Chia-Chen
    Lai, Hsin-Chih
    [J]. JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (03) : 615 - 622
  • [8] A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants
    Corrêa, NBO
    Péret, LA
    Penna, FJ
    Lima, RMLS
    Nicoli, JR
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (05) : 385 - 389
  • [9] De Grandi R, 2019, EUR REV MED PHARMACO, V23, P60, DOI 10.26355/eurrev_201903_17351
  • [10] Ferrarese R, 2018, EUR REV MED PHARMACO, V22, P7588, DOI 10.26355/eurrev_201811_16301